Vivani Medical (VANI)

• Market cap: $99.9M
• 1 day: -2.84%
• 5 days: -6.8%
• 1 month: -26.74%
• 3 months: 13.22%
• 6 months: 28.04%
• Year to date: 14.17%
• 1 year: 6.2%
• 5 years: -45.85%
• 10 years: -98.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Employees: 36